JNCI-Journal of the National Cancer Institute

Papers
(The H4-Index of JNCI-Journal of the National Cancer Institute is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group306
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics270
Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study167
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy156
Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis138
“When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials113
The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis112
State Variation in Low-Dose Computed Tomography Scanning for Lung Cancer Screening in the United States111
Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer106
Management of Cancer and Health After the Clinic Visit: A Call to Action for Self-Management in Cancer Care103
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial98
Annual Report to the Nation on the Status of Cancer, Part 2: Patient Economic Burden Associated With Cancer Care95
Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival93
Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Renal Cell Carcinoma89
Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling89
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer83
International Trends in the Incidence of Cancer Among Adolescents and Young Adults78
PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel–Treated Advanced Triple-Negative Breast Cancer78
Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening77
Accuracy and Efficiency of Deep-Learning–Based Automation of Dual Stain Cytology in Cervical Cancer Screening76
Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving Immunotherapy76
Effect of Aspirin on Cancer Incidence and Mortality in Older Adults75
Using Prediction Models to Reduce Persistent Racial and Ethnic Disparities in the Draft 2020 USPSTF Lung Cancer Screening Guidelines73
Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief Report72
Changes in Mammography Use by Women’s Characteristics During the First 5 Months of the COVID-19 Pandemic69
Association of the COVID-19 Pandemic With Patterns of Statewide Cancer Services67
Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States67
Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis66
Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study66
A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers63
Incident Type 2 Diabetes Duration and Cancer Risk: A Prospective Study in Two US Cohorts60
Comprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer59
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer58
The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort57
Health Insurance Coverage Disruptions and Cancer Care and Outcomes: Systematic Review of Published Research57
Estimation of the Number of Individuals Living With Metastatic Cancer in the United States57
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial56
Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer56
Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients56
Strategies to Prevent or Remediate Cancer and Treatment-Related Aging55
Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy54
Germline Cancer Predisposition Variants in  Pediatric Rhabdomyosarcoma: A Report From the Children’s Oncology Group54
Overall Survival of CDK4/6-Inhibitor–Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis54
A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer54
Evidence Gaps in Cancer Survivorship Care: A Report From the 2019 National Cancer Institute Cancer Survivorship Workshop52
The Affordable Care Act’s Medicaid Expansion and Impact Along the Cancer-Care Continuum: A Systematic Review51
All-Cause and Cardiovascular Disease Mortality Among Breast Cancer Survivors in CLUE II, a Long-Standing Community-Based Cohort50
Performance of Digital Breast Tomosynthesis, Synthetic Mammography, and Digital Mammography in Breast Cancer Screening: A Systematic Review and Meta-Analysis49
A Prognostic Predictive System Based on Deep Learning for Locoregionally Advanced Nasopharyngeal Carcinoma48
Association of Obesity With Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis48
0.059023141860962